![FDA approved Hemgenix based on safety and effectiveness evaluated in two studies of about 60 adult men.](https://abc17news.b-cdn.net/abc17news.com/2022/11/hypatia-h_a8fb5eedb0e08dd773c517e036dae81f-h_59a1c361cf3bc3612d3065246dfcdd16-300-375x225.jpg)
FDA approves $3.5 million treatment for hemophilia, now the most expensive drug in the world
By Deidre McPhillips, CNN The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug in the world. Hemgenix is a gene therapy to treat adults with hemophilia B, a genetic bleeding disorder
Continue Reading